Last reviewed · How we verify

Calcipotriene/betamethasone — Competitive Intelligence Brief

Calcipotriene/betamethasone (Calcipotriene/betamethasone) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D analog / Corticosteroid combination. Area: Dermatology.

marketed Vitamin D analog / Corticosteroid combination Vitamin D receptor (VDR) / Glucocorticoid receptor (GR) Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Calcipotriene/betamethasone (Calcipotriene/betamethasone) — Derm Research, PLLC. Calcipotriene is a vitamin D analog that regulates skin cell differentiation and proliferation, while betamethasone is a corticosteroid that suppresses inflammation and immune response in the skin.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Calcipotriene/betamethasone TARGET Calcipotriene/betamethasone Derm Research, PLLC marketed Vitamin D analog / Corticosteroid combination Vitamin D receptor (VDR) / Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin D analog / Corticosteroid combination class)

  1. Derm Research, PLLC · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Calcipotriene/betamethasone — Competitive Intelligence Brief. https://druglandscape.com/ci/calcipotriene-betamethasone. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: